Expertise in
4
conditions

Lugui R. Qiu

Tianjin, CN 
Expertise in
4
conditions
Tianjin, CN 

Overview

Lugui Qiu practices practicing medicine in Tianjin, China.

Qiu is highly rated in 4 conditions, according to our data. Their clinical expertise encompasses Multiple Myeloma, Waldenstrom Macroglobulinemia, Small Lymphocytic Lymphoma (SLL), and B-Cell Lymphoma.

They are actively involved in clinical research, co-authoring 93 peer reviewed articles and participating in 1 clinical trial.

Locations

Tianjin, China
Other Locations
National Health Commission Key Laboratory Of Endocrinology, Peking Union Medical College Hospital, Peking Union Medical College, Beijing, 100730, China
State Key Laboratory Of Experimental Hematology, Chinese Academy Of Medical Sciences And Peking Union Medical College, No. 288 Nanjing Road, 3000241, Xiaobailou, 300024, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Multicenter, Randomized, Double-blind, Parallel-controlled Trial to Compare the Bioequivalence and Safety of the Recombinant Human-Mouse Chimeric Anti-CD20 Monoclonal Antibody Injection (JHL1101) and Rituximab Injection in CD20 Positive B Cell Lymphoma Patients
A Multicenter, Randomized, Double-blind, Parallel-controlled Trial to Compare the Bioequivalence and Safety of the Recombinant Human-Mouse Chimeric Anti-CD20 Monoclonal Antibody Injection (JHL1101) and Rituximab Injection in CD20 Positive B Cell Lymphoma Patients
Enrollment Status: Terminated
Publish Date: January 09, 2020
Intervention Type: Biological
Study Phase: Phase 1

93 Total Publications

Circulating tumor cells identify a disseminated genomic high-risk phenotype within IMS-IMWG 2025 staging in newly diagnosed multiple myeloma.
Circulating tumor cells identify a disseminated genomic high-risk phenotype within IMS-IMWG 2025 staging in newly diagnosed multiple myeloma.
Journal: Leukemia
Published: June 09, 2026

Frequently Asked Questions about Lugui R. Qiu

Is Lugui R. Qiu a top-rated expert for Multiple Myeloma?

MediFind is an objective health platform that identifies experts based on real-world data. Lugui R. Qiu is classified as an Advanced expert for Multiple Myeloma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Lugui R. Qiu participate in research or clinical trials?

Yes. Lugui R. Qiu has published 93 articles and abstracts on conditions like Multiple Myeloma. You can view a list of Lugui R. Qiu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Qiu's expertise for a condition
ConditionClose
      View All 15 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile